Skip to main content
Menu

Select a tool from the sidebar

Portfolio
Loading...
Bristol-Myers Squibb Company (BMY)
BMY
Bristol-Myers Squibb Company (BMY)
59.7000 $
+0.1100 (%+0.18)

BMY: Bristol-Myers Squibb Company Stock Live Price Graph

Bristol-Myers Squibb Company stock live price (US Dollar), charts and analysis. Get BMY stock market news.

Bristol-Myers Squibb Company (BMY)

Loading chart...

Industry
NYSE
Sector
-
Exchange
New York Stock Exchange

About the company

Bristol-Myers Squibb Company operates as a global biopharmaceutical entity, actively involved in the research, development, licensing, production, and worldwide commercialization of its medicinal portfolio. The company's therapeutic areas span hematology, oncology, cardiovascular health, immunology, fibrotic conditions, neuroscience, and infectious diseases like COVID-19. Its significant pharmaceutical offerings include Revlimid, an oral immunomodulatory agent for multiple myeloma, and Eliquis, an oral anticoagulant crucial for reducing stroke risk and systemic embolism in non-valvular atrial fibrillation, as well as treating deep vein thrombosis and pulmonary embolism. The portfolio also features Opdivo, utilized across various anti-cancer indications; Pomalyst/Imnovid, prescribed for multiple myeloma patients; and Orencia, targeting active rheumatoid arthritis and psoriatic arthritis in adults. Other key therapies are Sprycel, employed in the management of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy, indicated for patients with unresectable or metastatic melanoma; and Abraxane, a protein-bound chemotherapy formulation. Furthermore, Bristol-Myers Squibb offers Reblozyl, addressing anemia in adult patients with beta thalassemia; Empliciti, another treatment option for multiple myeloma; and Zeposia, designed to treat relapsing forms of multiple sclerosis. Revolutionary treatments like Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for adult patients battling relapsed or refractory large B-cell lymphoma, are also part of its lineup. Completing its product range are Inrebic, an oral kinase inhibitor specifically for adult myelofibrosis, and Onureg, used in the treatment of adult patients with acute myeloid leukemia (AML). Bristol-Myers Squibb distributes its pharmaceutical products through a diverse network encompassing wholesalers, distributors, pharmacies, retail outlets, hospitals, clinics, and governmental organizations. Founded in 1887 and formerly known as Bristol-Myers Company, the firm maintains its headquarters in New York, New York.

Company profile

Employees
32,500
Field of activity
Drug Manufacturers - General

Market News & Analysis

Dividend History

Cash dividends

Latest dividend (gross per share)
$0.63
Highest dividend $0.63
Average dividend $0.63
Lowest dividend $0.63
PaymentGross / shareNet / shareYieldPer 1,000 TRY
-$0.63$0.634.12%-

What Is BMY? Live BMY Prices and Analysis

Bristol Myers Squibb Company (BMY) is a global biopharmaceutical company engaged in the discovery, development, and delivery of innovative medicines for patients with serious diseases. With a strong portfolio of pharmaceutical products, BMY plays a crucial role in the healthcare sector, particularly in oncology, immunology, cardiology, and fibrosis. Investors closely monitor BMY due to its significant market presence and potential for growth in the biopharmaceutical industry.

The importance of BMY in the stock market stems from its ability to develop groundbreaking therapies that can address unmet medical needs, making it a key player in an ever-evolving healthcare landscape. As a result, it garners attention from both institutional and retail investors, especially in light of its robust pipeline and earnings potential.

Frequently asked questions

What is the BMY stock price?

The latest BMY (Bristol-Myers Squibb Company (BMY)) stock price is 59.7000 USD. Follow the live quote and chart on this page for real-time updates.

What are BMY's intraday ceiling and floor prices?

For BMY, the intraday ceiling is 60.1000 USD and the floor is 59.0100 USD. These levels may update during the session.

What is BMY's previous closing price?

The previous closing price for BMY is 59.5900 USD.

What is BMY's trading volume?

The current trading volume for BMY is 11,037,974. Volume can change throughout the session.

Where can I see the live BMY price?

You can follow the live BMY (Bristol-Myers Squibb Company (BMY)) price in the quote area and chart at the top of this Investvio overview page.

Where can I see BMY historical prices and charts?

The current price chart for BMY (Bristol-Myers Squibb Company (BMY)) is on this overview page. For longer historical prices and archive data, open the Archive tab and choose a period to review past performance.